Larson R - Search Results

1

Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation.

Pollyea DA, Artz AS, Stock W, Daugherty C, Godley L, Odenike OM, Rich E, Smith SM, Zimmerman T, Zhang Y, Huo D, Larson R, van Besien K. Pollyea DA, et al. Among authors: larson r. Bone Marrow Transplant. 2007 Dec;40(11):1027-32. doi: 10.1038/sj.bmt.1705852. Epub 2007 Sep 10. Bone Marrow Transplant. 2007. PMID: 17846595 Clinical Trial.

2

Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.

Qian Z, Fernald AA, Godley LA, Larson RA, Le Beau MM. Qian Z, et al. Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14925-30. doi: 10.1073/pnas.222491799. Epub 2002 Nov 4. Proc Natl Acad Sci U S A. 2002. PMID: 12417757 Free PMC article.

3

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J, Vardiman JW, Rowley JD, Larson RA. Smith SM, et al. Blood. 2003 Jul 1;102(1):43-52. doi: 10.1182/blood-2002-11-3343. Epub 2003 Mar 6. Blood. 2003. PMID: 12623843 Free article.

4

Progress and challenges in the therapy of adult acute lymphoblastic leukemia.

Kebriaei P, Larson RA. Kebriaei P, et al. Curr Opin Hematol. 2003 Jul;10(4):284-9. doi: 10.1097/00062752-200307000-00006. Curr Opin Hematol. 2003. PMID: 12799534 Review.

5

Kebriaei P, Winter JN, Laport GG, Le Beau MM, Dewald G, Larson RA. Kebriaei P, et al. Leuk Res. 2004 May;28(5):537-40. doi: 10.1016/j.leukres.2003.09.010. Leuk Res. 2004. PMID: 15068908

6

Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection.

Van Besien K, Smith S, Anastasi J, Larson R, Thirman M, Odenike T, Stock W. Van Besien K, et al. Among authors: larson r. Blood. 2004 Jun 1;103(11):4373-4. doi: 10.1182/blood-2004-02-0583. Blood. 2004. PMID: 15155474 Free article. No abstract available.

7

A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases.

Odenike OM, Sobecks RM, Janisch L, Huo D, Zimmerman TM, Daugherty CK, Ratain MJ, Larson RA. Odenike OM, et al. Cancer Chemother Pharmacol. 2004 Dec;54(6):553-61. doi: 10.1007/s00280-004-0857-3. Epub 2004 Sep 2. Cancer Chemother Pharmacol. 2004. PMID: 15349753 Clinical Trial.

8

Dose-ranging pharmacodynamic study of tipifarnib (R115777) in patients with relapsed and refractory hematologic malignancies.

Zimmerman TM, Harlin H, Odenike OM, Berk S, Sprague E, Karrison T, Stock W, Larson RA, Ratain MJ, Gajewski TF. Zimmerman TM, et al. J Clin Oncol. 2004 Dec 1;22(23):4816-22. doi: 10.1200/JCO.2004.03.200. J Clin Oncol. 2004. PMID: 15570084 Clinical Trial.

9

Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805.

Byrd JC, Peterson BL, Gabrilove J, Odenike OM, Grever MR, Rai K, Larson RA; Cancer and Leukemia Group B. Byrd JC, et al. Among authors: larson ra. Clin Cancer Res. 2005 Jun 1;11(11):4176-81. doi: 10.1158/1078-0432.CCR-04-2276. Clin Cancer Res. 2005. PMID: 15930354 Clinical Trial.

10

Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples.

Stock W, Yu D, Karrison T, Sher D, Stone RM, Larson RA, Bloomfield CD. Stock W, et al. Int J Oncol. 2006 May;28(5):1099-103. Int J Oncol. 2006. PMID: 16596225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,846 results

Search Page

Filters